Clinical Trials Browser

Phase 3 × INDUSTRY × idecabtagene vicleucel × Clear all

NCT06045806 2026-03-05

KarMMa-9

Phase 3 Active not recruiting

Multiple Myeloma

NCT03651128 2022-12-15

KarMMa-3

Phase 3 Active not recruiting

Multiple Myeloma, Recurrence